Data / Form D filings / Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc.: Form D filings
Panbela Therapeutics, Inc., a pharmaceuticals company in Waconia, MN, filed 8 Form D notices with the SEC between 2016 and 2024. The latest, on January 5, 2024, reports $2 million sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 712 Vista Blvd #305, Waconia, MN, 55387
- Phone
- (952) 479-1196
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1029125
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | New notice | Indefinite | $2,000,000 | 2 | Dec 21, 2023 | sec.gov | |
| Nov 17, 2023 | New notice | Indefinite | $3,322,800 | 3 | Nov 2, 2023 | sec.gov | |
| Jun 29, 2022 | New notice | Indefinite | $8,800,000 | 70 | Jun 15, 2022 | sec.gov | |
| Sep 9, 2019 | New notice | Indefinite | $2,500,000 | 38 | Aug 23, 2019 | sec.gov | |
| Jan 4, 2019 | New notice | $2,000,000 | $1,358,638 | $641,362 | 15 | Dec 21, 2018 | sec.gov |
| Mar 6, 2018 | New notice | $20,000,000 | $840,000 | $19,160,000 | 13 | Feb 20, 2018 | sec.gov |
| Mar 6, 2017 | New notice | $5,000,000 | $1,495,000 | $3,505,000 | 14 | Feb 17, 2017 | sec.gov |
| Jun 27, 2016 | New notice | $5,000,000 | $1,951,000 | $3,049,000 | 27 | Jun 10, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jennifer K. Simpson | Executive Officer, Director | |
| Daniel S. Donovan | Director | |
| Jeffrey S. Mathiesen | Director | |
| Susan K. Horvath | Executive Officer | |
| Arthur J. Fratamico | Director | |
| Jeffrey E. Jacob | Director | |
| Michael T. Cullen | Director | |
| Robert S. Schemel | Director |
Every Form D from the week of Jan 1, 2024 · All recent filings in Minnesota · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Panbela Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.